Synthesis of simple analogues of methyllycaconitine - An efficient method for the preparation of the N-substituted anthranilate pharmacophore

Tetrahedron

Volumn 60, Issue 28, 2004, Pages 5953-5963

  Barker, David ^a   Brimble, Margaret A ^b   McLeod, Malcolm D ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Alkaloids; Anthranilate esters; Methyllycaconitine; Nicotinic acetylcholine receptors

Indexed keywords

2 (2'' METHYLSUCCINIMIDO)BENZOATE; ACID ANHYDRIDE; ALKALOID DERIVATIVE; ANTHRANILIC ACID; BENZOIC ACID DERIVATIVE; METHYLLYCACONITINE; SODIUM BOROHYDRIDE; TRIFLUOROACETIC ACID; UNCLASSIFIED DRUG;

ACONITUM; ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; ESTERIFICATION; LARKSPUR; PHARMACOPHORE; PRIORITY JOURNAL;

ACONITUM; DELPHINIUM;

EID: 2942750323     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2004.05.024     Document Type: Article

References (33)

1. Dwoskin L.P., Crooks P.A. J. Pharmacol. Exp. Ther. 298:2001;395
2. Holladay M.W., Dart M.J., Lynch J.K. J. Med. Chem. 40:1997;4169
3. Hucho F., Weise C. Angew. Chem. Int. Ed. 40:2001;3100
4. Brejc K., van Dijk W., Klaassen R.V., Schuurmans M., van der Oost J., Smit A.B., Sixma T.K. Nature. 411:2001;269
5. Paterson D., Nordberg A. Prog. Neurobiol. 61:2000;75
6. Davies A.R.L., Hardick D.J., Blagbrough I.S., Potter B.V.L., Wolstenholme A.J., Wonnacott S. Neuropharmacology. 38:1999;679
7. Marks M.J., Stitzel J.A., Romm E., Wehner J.M., Collins A.C. Mol. Pharmacol. 30:1986;427
8. McIntosh J.M., Santos A.D., Olivera B.M. Annu. Rev. Biochem. 68:1999;59
9. Manske R.H. Can. J. Res. 16B:1938;57
10. Pelletier S.W., Joshi B.S. Pelletier S.W. Alkaloids: Chemical and Biological Perspectives. Vol. 7:1991;297 Springer, New York
11. Hardick D.J., Blagbrough I.S., Cooper G., Potter B.V.L., Critchley T., Wonnacott S. J. Med. Chem. 39:1996;4860
12. Jennings K.R., Brown D.G., Wright P.D. Jr. Experientia. 42:1986;611
13. Bergmeier S.C., Lapinsky D.J., Free R.B., McKay D.B. Bioorg. Med. Chem. Lett. 9:1999;2263
14. Doisy X., Blagbrough I.S., Wonnacott S., Potter B.V.L. Pharm. Pharmacol. Commun. 4:1998;313
15. Trigg W.J., Hardick D.J., Grangier G., Wonnacott S., Lewis T., Rowan M.G., Potter B.V.L., Blagbrough I.S. ACS Symp. Ser. 686:1998;194
16. Baillie L.C., Bearder J.R., Li W.-S., Sherringham J.A., Whiting D.A. J. Chem. Soc., Perkin Trans. 1. 1998;4047
17. Kraus G.A., Dneprovskaia E. Tetrahedron Lett. 39:1998;2451
18. Davies A.R.L., Hardick D.J., Blagbrough I.S., Potter B.V.L., Wolstenholme A.J., Wonnacott S. Biochem. Soc. Trans. 25:1997;545S
19. Bryant D.L., Free R.B., Thomasy S.M., Lapinsky D.J., Ismail K.A., McKay S.C., Bergmeier S.C., McKay D.B. Neurosci. Res. 42:2002;57
20. For an earlier communication on this work see: Barker D., McLeod M.D., Brimble M.A., Savage G.P. Tetrahedron Lett. 42:2001;1785
21. Staiger R.P., Miller E.B. J. Org. Chem. 24:1959;1214
22. Venuti M.C. Synthesis. 1982;266
23. Hardick D.J., Blagbrough I.S., Wonnacott S., Potter B.V. Tetrahedron Lett. 35:1994;3371
24. Coates P.A., Blagbrough I.S., Hardick D.J., Rowan M.G., Wonnacott S., Potter B.V.L. Tetrahedron Lett. 35:1994;8701
25. Blagbrough I.S., Coates P.A., Hardick D.J., Lewis T., Rowan M.G., Wonnacott S., Potter B.V.L. Tetrahedron Lett. 35:1994;8705
26. Coates P.A., Blagbrough I.S., Rowan M.G., Potter B.V.L., Pearson D.P.J., Lewis T. Tetrahedron Lett. 35:1994;8709
27. Coates P.A., Blagbrough I.S., Rowan M.G., Pearson D.P.J., Lewis T., Potter B.V.L. J. Pharm. Pharmacol. 48:1996;210
28. Navarro H., Zhong D., Abraham P., Xu H., Carroll F.I. J. Med. Chem. 43:2000;142
29. Schepartz A., Breslow R. J. Am. Chem. Soc. 109:1987;1814
30. Neises B., Steglich W. Angew. Chem. Int. Ed. Engl. 17:1978;522
31. Shimizu B., Ogiso A., Iwai I. Chem. Pharm. Bull. 11:1963;333
32. Saitoh L., Shiina I., Mukaiyama T. Chem. Lett. 7:1998;679
33. Rao D.V., Rao V.V.R., Raghunanda R. Indian J. Chem. 24B:1985;988